Inovio Pharmaceuticals (INO) Financials

$1.13

$-0.04 (-3.02%)

As on 16-Sep-2026 15:34EDT

Market cap

$129 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

30.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	-0.07	0.07	0.22	0.83	10.26	1.77
Cost of Revenue	2.25	2.99	3.13	3.50	5.50	4.73
Gross Profit	-2.25	0.07	-2.91	0.83	10.26	1.77
Operating Expenses	77.76	86.89	111.09	144.77	277.84	302.99
Operating Profit (EBIT)	-79.26	-86.82	-112.40	-143.94	-267.57	-301.22
Other Income	--	--	--	--	-1.24	3.27
Profit before Tax	-67.43	-84.95	-107.25	-135.12	-279.82	-303.66
Provision for Tax	--	--	-107,146.87	0.00	2.17	0.43
Profit after Tax (Net Income)	-67.43	-84.95	-107.25	-135.12	-279.82	-303.66
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-107.25	-135.12	-279.82	-303.66

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	4.37	24.10	68.50	117.35	222.36	399.67
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	5.10	6.55	9.37	11.03	29.30	30.53
Current Liabilities	39.92	43.67	35.33	42.57	96.87	65.74
Total Liabilities	89.30	74.31	113.20	170.95	348.53	495.94

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	9.48	13.19	15.37	17.84	33.29	47.50
Current Assets	39.91	61.12	97.83	153.11	315.24	448.44
Total Assets	89.30	74.31	113.20	170.95	348.53	495.94
Total Debt*	8.00	9.37	11.87	30.21	32.07	33.02
Net Current Assets	--	17.45	62.50	110.54	218.37	382.70

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-88.63	-104.08	-124.37	-216.22	-215.71
Cash Flow from Investing Activities	--	14.04	104.07	87.36	109.59	-175.34
Cash from Financing Activities	--	53.05	51.48	5.00	81.84	211.50
Net Cash Inflow / Outflow	--	--	--	--	-24.79	-179.55

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.18	-1.23	-3.95	-5.93	-13.08	-1.44
Cash EPS ($)	--	-1.19	-3.83	-5.72	-12.83	-1.42
Adjusted Book Value ($)	--	0.35	2.52	5.15	10.40	1.90
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.28	-3.83	-5.46	-10.11	-1.03
Free Cash Flow per Share ($)	--	-1.29	-3.85	-5.47	-10.15	-1.03

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-149.25	-94.11	-67.22	-81.45	-65.10
ROE (%)	-473.71	-183.47	-115.42	-79.55	-89.97	-70.55
ROA (%)	-71.26	-90.61	-75.49	-52.02	-66.27	-58.64
EBIT Margin (%)	103,189.40	-130,000.00	-49,172.60	-16,092.90	-2,693.35	-16,976.28
Net Margin (%)	103,189.40	-130,000.00	-49,254.27	-16,239.87	-3,103.06	-6,016.83
Cash Profit Margin (%)	0.05	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-135.84	-0.70	-0.74	-0.92	4.78	-0.76
EBIT Growth (%)	99.73	20.67	20.03	51.56	8.26	-95.40
Net Profit Growth (%)	23.17	20.80	20.62	51.71	7.85	-82.47
EPS Growth (%)	59.98	0.69	0.33	0.55	-8.06	-0.43
Book Value Growth (%)	-92.71	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.41	-0.46	-0.09	-0.12	-3.46
Price / Book Value	30.51	4.98	0.73	0.10	0.15	2.63
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.09	-0.87	0.31	0.79	0.69	-2.30
Close Price ($)	1.10	1.74	1.83	6.12	18.72	59.88
High Price ($)	2.98	2.98	87.84	23.88	63.24	228.00
Low Price ($)	1.03	1.30	1.74	3.84	16.56	59.88
Market Cap ($ Cr)	129.25	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.39	0.17	0.26	0.14	0.08
Short term debt to equity ratio	0.66	0.12	0.04	0.16	0.01	0.01
Current Ratio	1.00	1.40	2.77	3.60	3.25	6.82
Quick Ratio	1.00	--	--	--	--	--
Interest Coverage	--	--	-602.12	-109.50	-220.42	-155.59

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	0.69	550.64	289.09	114.38	452.57
Asset Turnover	0.00	0.00	0.00	0.00	0.02	0.00
Receivable days	--	3,352.46	3,022.80	3,104.47	351.83	2,788.19
Inventory Days	--	--	--	--	--	--
Payable days	--	553.70	647.11	1,341.27	1,630.05	1,136.54
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.